Flexible Electronics News

Grapheal Raises €1.9 million to Develop Biosensors, Fast Digital COVID Tests

The TestNPass is already being tested in an observational clinical trial with real samples at the University Hospital of Grenoble, France.

Author Image

By: Anthony Locicero

Copy editor, New York Post

Grapheal is a Graphene Flagship Associate Member with experience creating graphene-based wearable patches for the remote monitoring of chronic wounds.    Now, it raised €1.9 million in seed financing from Belgian incubator Novalis Biotech and private investors to further develop this technology, as well as to advance the creation of a digital, high-speed test for COVID-19.    Thanks to the high sensitivity of graphene, this novel device would improve screening activities in high-traffic ...

Continue reading this story and get 24/7 access to Ink World magazine for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Ink World magazine Newsletters